比较估测胎儿体重与联合筛查模型在孕晚期预测胎儿生长受限的价值
本研究为前瞻性队列(1590例单胎)中的巢式病例对照研究,比较孕晚期(32+0至36+6周)仅用估测胎儿体重百分位(EFWc)与联合母体特征、胎儿胎盘超声及母体生化标志物的模型预测小于胎龄儿(SGA)和晚发型胎儿生长受限(FGR)的性能。联合模型在10%假阳性率下对SGA和FGR的检出率分别为61%和77%,优于单用EFWc的52%和64%(P<0.001和P=0.002)。
要点
- 孕晚期单用EFWc在10%假阳性率下可检出52%的SGA和64%的FGR。
- 联合母体特征、EFWc、UtA-PI、PlGF和雌三醇(SGA加脂质运载蛋白-2)的模型检出率更高。
- 联合模型对SGA和FGR的检出率分别为61%和77%,均优于单用EFWc。
核心结论
- 包含母体特征、胎儿胎盘超声和母体生化标志物的多变量整合模型,与单用EFWc筛查相比,在32-36周对SGA和FGR的检出有适度改善。
研究设计与样本
- 前瞻性队列(1590例单胎妊娠)中的巢式病例对照研究;SGA组175例,对照组875例;于32+0至36+6周评估母体基线特征、平均动脉压、胎儿胎盘超声及循环生化标志物(PlGF、脂质运载蛋白-2、非结合雌三醇、抑制素A)。
关键影像表现/征象
- SGA病例的EFWc、CPR Z评分及母体血清非结合雌三醇和PlGF浓度显著低于对照组。
- SGA病例的平均UtA-PI Z评分及脂质运载蛋白-2和抑制素A浓度显著高于对照组。
诊断标准与关键数值
- SGA定义为出生体重低于定制标准的第10百分位。
- FGR定义为SGA病例中出生体重低于第3百分位和/或UtA-PI异常和/或CPR异常。
- 单用EFWc在10%假阳性率下检出52%的SGA(AUC 0.82,95%CI 0.77-0.85)和64%的FGR(AUC 0.86,95%CI 0.81-0.91)。
- 联合模型(先验风险、EFWc、UtA-PI、PlGF和雌三醇,SGA加脂质运载蛋白-2)在10%假阳性率下检出61%的SGA(AUC 0.86,95%CI 0.83-0.89)和77%的FGR(AUC 0.92,95%CI 0.88-0.95)。
- 联合模型预测SGA和FGR的性能显著优于单用EFWc(P<0.001和P=0.002)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the performance of third-trimester screening, based on estimated fetal weight centile (EFWc) vs a combined model including maternal baseline characteristics, fetoplacental ultrasound and maternal biochemical markers, for the prediction of small-for-gestational-age (SGA) neonates and late-onset fetal growth restriction (FGR).
METHODS: This was a nested case-control study within a prospective cohort of 1590 singleton gestations undergoing third-trimester (32 + 0 to 36 + 6 weeks' gestation) evaluation. Maternal baseline characteristics, mean arterial pressure, fetoplacental ultrasound and circulating biochemical markers (placental growth factor (PlGF), lipocalin-2, unconjugated estriol and inhibin A) were assessed in all women who subsequently delivered a SGA neonate (n = 175), defined as birth weight < 10th centile according to customized standards, and in a control group (n = 875). Among SGA cases, those with birth weight < 3rd centile and/or abnormal uterine artery pulsatility index (UtA-PI) and/or abnormal cerebroplacental ratio (CPR) were classified as FGR. Logistic regression predictive models were developed for SGA and FGR, and their performance was compared with that obtained using EFWc alone.
RESULTS: In SGA cases, EFWc, CPR Z-score and maternal serum concentrations of unconjugated estriol and PlGF were significantly lower, while mean UtA-PI Z-score and lipocalin-2 and inhibin A concentrations were significantly higher, compared with controls. Using EFWc alone, 52% (area under receiver-operating characteristics curve (AUC), 0.82 (95% CI, 0.77-0.85)) of SGA and 64% (AUC, 0.86 (95% CI, 0.81-0.91)) of FGR cases were predicted at a 10% false-positive rate. A combined screening model including a-priori risk (maternal characteristics), EFWc, UtA-PI, PlGF and estriol (with lipocalin-2 for SGA) achieved a detection rate of 61% (AUC, 0.86 (95% CI, 0.83-0.89)) for SGA cases and 77% (AUC, 0.92 (95% CI, 0.88-0.95)) for FGR. The combined model for the prediction of SGA and FGR performed significantly better than did using EFWc alone (P < 0.001 and P = 0.002, respectively).
CONCLUSIONS: A multivariable integrative model of maternal characteristics, fetoplacental ultrasound and maternal biochemical markers modestly improved the detection of SGA and FGR cases at 32-36 weeks' gestation when compared with screening based on EFWc alone. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Miranda J, Rodriguez-Lopez M, Triunfo S, et al. Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester. Ultrasound Obstet Gynecol. 2017. PMID: 28004439. doi:10.1002/uog.17393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。